ZIMLAB — Zim Laboratories Cashflow Statement
0.000.00%
- IN₹4.26bn
- IN₹5.24bn
- IN₹3.67bn
- 60
- 40
- 42
- 45
Annual cashflow statement for Zim Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 0.686 | 154 | 210 | 354 | 236 |
Depreciation | |||||
Non-Cash Items | 118 | 100 | 59.8 | 46.9 | 60.5 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -44 | -93.5 | 61.5 | -200 | -294 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 219 | 319 | 492 | 375 | 163 |
Capital Expenditures | -185 | -64.8 | -152 | -367 | -739 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -5.31 | 5.96 | 6.54 | 4.64 | 9.11 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -191 | -58.8 | -146 | -362 | -730 |
Financing Cash Flow Items | -139 | -151 | -13.4 | -59.5 | -74.6 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -25.1 | -260 | -330 | 5.46 | 595 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 9.62 | -0.685 | 20.3 | 30 | 31.8 |